Klapperich Lab:Notebook/Lab Meeting Notes/2009/09/08: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 29: Line 29:
* CMK: PCR 2 paper draft. <br>
* CMK: PCR 2 paper draft. <br>
* CMK: PCR 1 draft. Analytical Chem. <br>
* CMK: PCR 1 draft. Analytical Chem. <br>
* on-chip PCR on a series of diluted lambda phage DNA. LOD for ABI is 10<sup>-9</sup>g/ul
* on-chip PCR on a series of diluted lambda phage DNA. LOD for ABI is 10<sup>-9</sup>g/ul <br>
  on-chip PCR have the same sensitivity.<br>
* on-chip PCR have the same sensitivity.<br>
* With new syring and tubing, on-chip PCR for the patient sample does not have detectable amplified product. however, the postitive control on the thermal cycle works good. <br>
* With new syring and tubing, on-chip PCR for the patient sample does not have detectable amplified product. however, the postitive control on the thermal cycle works good. <br>
* New primers? <br>
* New primers? <br>
Line 36: Line 36:
<br>
<br>
† HDA (Lead: Jaephil)<br>
† HDA (Lead: Jaephil)<br>
* Start planning R01 for Submission on 2/5/10. MM, JD, CMK. <br>
* JD working on paper. Will deliver to MM this week. <br>
* Figures discussion. <br>
*<br>
*<br>


Line 60: Line 63:
* Cathie submitted the companion BU IRB form for exemption. <br>
* Cathie submitted the companion BU IRB form for exemption. <br>
<br>
<br>
PCR (will get absorbed into the Flu agenda item at the top) <br>
RCA/HDA<br>


<br>
† RCA/HDA<br>
* Start planning R01 for Submission on 2/5/10. MM, JD, CMK. <br>
* JD working on paper. Will deliver to MM this week. <br>
* Figures discussion. <br>
<br>
<br>
* PATH Grant <br>
* PATH Grant <br>

Revision as of 11:09, 26 August 2009

Project name <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page
<html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html>

8 September 2009 Lab Meeting

  • Attending:
  • Missing:
  • Presentation: Cathie: Fill in the Blanks Document on FLU. Delegation of Tasks. Definition of "Tiger Teams."


‡ Announcements


‡ Flu R01:Integration
* Need to update IBC to include rDNA work.

† Sample Concentration (Lead: Jane)

  • Volume collection issues at this time. Where is the loss?
  • Alexa Fluo-488 succinimidyl ester (Molecular Probes) stains the flu virus fluorescent.
  • The current problem is not how to visualize virus right now, because the design is clearly not optimized for collecting all the samples at the outlet. The major loss is from sample handling instead of from non specific binding to the material.


† SPE Column Optimization for RNA. (Lead: Sonali)

  • RNA extraction troubleshooting. Do deinhibition of monolith components. Test those with the Ambion RNAse kit.


† PCR - CMI (Lead: Qingqing)

  • QQ will work on the initial integration steps of SPE + RT (resevoir)+ PCR.
  • CMK: PCR 2 paper draft.
  • CMK: PCR 1 draft. Analytical Chem.
  • on-chip PCR on a series of diluted lambda phage DNA. LOD for ABI is 10-9g/ul
  • on-chip PCR have the same sensitivity.
  • With new syring and tubing, on-chip PCR for the patient sample does not have detectable amplified product. however, the postitive control on the thermal cycle works good.
  • New primers?
  • Double PCR on chip.


† HDA (Lead: Jaephil)

  • Start planning R01 for Submission on 2/5/10. MM, JD, CMK.
  • JD working on paper. Will deliver to MM this week.
  • Figures discussion.

‡ Coulter Flu Fraunhofer Project (Lead: Sonali, Team: Sonali, Jessie, Cathie, CMI Folks, Qingqing)

  • Meeting time will have to move


‡ Agilent Automated Sample Preparation (Lead: Alex)

  • With Straws in Parallel at this point. Speeding up the assay.
  • Waiting for the machine.


‡ COBRA (Lead: Jaephil, Team: Cathie, Jane for virus only, PHO folks)

  • Update on concentration of live bugs? MSSA?
  • Virus concentration (dialyzed against PBS, no SERS signal, dialyze against water now).
  • paper 1: Evap with Sol Gel substrate. Not integrated. MSSA, E coli.


‡ Biointerfaces group (Lead: MinCheol, Team: Cathie, MCK, Wong and Meller folks)

  • New fabrcation in process.
  • took SEM images of parallelized designs, will show them if possible in the meeting.
  • Through SEM images, we found the smallest feature size is 1.2 um.
* set up 2 week check in meeting with team. 


‡ CIMIT- Sepsis (Lead:Cathie, Team:TBA)

  • IRB approved.
  • Cathie submitted the companion BU IRB form for exemption.


† RCA/HDA


  • PATH Grant
  • Frank J.
  • 12 mos, 24 mos. working prototypes of SNAP.


† Silica Optimization (Lambda): (get absorbed into the flu agenda item at top)

  • August-18-presentation [1]
  • Results Summary of Aug-18-09 [2]
  • Amorphous Chip results [3]